| Not Yet Recruiting | A Clinical Study of ZL-85FA Tablets Advanced Solid Tumor | Phase 1 / Phase 2 | 2026-06-30 |
| Recruiting | A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolera MF | Phase 2 | 2026-03-18 |
| Recruiting | A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis MF | Phase 3 | 2026-02-13 |
| Recruiting | A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2026-02-03 |
| Recruiting | Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera Polycythemia Vera (PV) | Phase 2 | 2025-09-23 |
| Recruiting | A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma Recurrent and Refractory Diffuse Large B-cell Lymphoma | Phase 3 | 2025-07-18 |
| Completed | A Pharmacokinetic Study of the Food Effect on Flonoltinib Maleate Tablets Heathly Subjects | Phase 1 | 2024-08-04 |
| Recruiting | A Clinical Study of Purinostat Mesylate for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2024-05-08 |
| Recruiting | A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis MF,PMF,PPV-MF,PET-MF | Phase 2 | 2024-05-06 |
| Active Not Recruiting | A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma an Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) | Phase 2 | 2024-04-14 |
| Recruiting | Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed o Relapsed or Refractory Multiple Myeloma (RRMM) | Phase 1 / Phase 2 | 2024-03-25 |
| Completed | ZL-82 Double-blind Clinical Trial Healthy Person | Phase 1 | 2024-03-19 |
| Completed | A Phase I Clinical Study of Flonoltinib Maleate Tablets in Healthy Subjects Heathly Subjects | Phase 1 | 2024-03-18 |
| Completed | Phase I Clinical Study of ZL-82 Tablets Rheumatoid Arthritis (RA), Inflammatory Bowel Disease - IBD1 | Phase 1 | 2023-04-09 |
| Unknown | Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection COVID-19 | N/A | 2023-01-19 |
| Active Not Recruiting | Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lym Diffuse Large B Cell Lymphoma，DLBCL | Phase 2 | 2022-11-08 |
| Completed | Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative Myeloproliferative Neoplasm (MPN), Myelofibrosis，MF | Phase 1 / Phase 2 | 2021-12-27 |
| Unknown | Study of Flonoltinib Maleate Tablets in the Treatment of Proliferative Bone Marrow Tumors Myeloproliferative Neoplasm (MPN), Myelofibrosis，MF | Phase 1 | 2021-11-12 |
| Completed | Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-pre Diffuse Large B Cell Lymphoma，DLBCL | Phase 1 | 2020-08-10 |